Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Autor: M. Opdam, V. van der Noort, M. Kleijn, A. Glas, I. Mandjes, S. Kleiterp, F. S. Hilbers, D. T. Kruger, A. D. Bins, P. C. de Jong, P. P. J. B. M. Schiphorst, T. van Dalen, B. Flameling, R. C. Rietbroek, A. Beeker, S. M. van den Heiligenberg, S. D. Bakker, A. N. M. Wymenga, I. M. Oving, R. M. Bijlsma, P. J. van Diest, J. B. Vermorken, H. van Tinteren, S. C. Linn

Publikováno v: Breast cancer research and treatment, 194(2), 265-278. Springer New York
Breast cancer research and treatment
Breast Cancer Research and Treatment, 194(2), 265-278. Springer New York
Opdam, M, van der Noort, V, Kleijn, M, Glas, A, Mandjes, I, Kleiterp, S, Hilbers, F S, Kruger, D T, Bins, A D, de Jong, P C, Schiphorst, P P J B M, van Dalen, T, Flameling, B, Rietbroek, R C, Beeker, A, van den Heiligenberg, S M, Bakker, S D, Wymenga, A N M, Oving, I M, Bijlsma, R M, van Diest, P J, Vermorken, J B, van Tinteren, H & Linn, S C 2022, ' Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature ', Breast Cancer Research and Treatment, vol. 194, no. 2, pp. 265-278 . https://doi.org/10.1007/s10549-022-06618-z

Purpose Guidelines recommend endocrine treatment for estrogen receptor-positive (ER+) breast cancers for up to 10 years. Earlier data suggest that the 70-gene signature (MammaPrint) has potential to select patients that have an excellent survival wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff14e4330cdee35c7a55ca1f5f2e824
https://doi.org/10.1007/s10549-022-06618-z

[Oncology is not waiting for 'shared decision-making' Patients and doctors generally reach consensus]

Autor: A N M, Wymenga

Publikováno v: Nederlands tijdschrift voor geneeskunde. 161

In recent times, the importance of shared decision-making (SDM) when making medical decisions has been emphasised. In general, SDM is seen as a consultative communication style, mainly used in reaching important, preference-sensitive decisions when m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2c94a256deb0625f94b6e407a4970b61
https://pubmed.ncbi.nlm.nih.gov/28351442

Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands

Autor: E F M M, van Dijk, M, Coşkuntürk, A T, Zuur, J, van der Palen, W T A, van der Graaf, J N H, Timmer-Bonte, A N M, Wymenga

Publikováno v: The Netherlands journal of medicine. 74(7)

In the past years, interest in patient treatment preferences is growing. Our objectives were: (1) to assess and compare the minimal required benefit for patients with cancer, patients without cancer and healthcare professionals to make chemotherapy a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::58734077b73d0ea446b54b9a45c412cf
https://pubmed.ncbi.nlm.nih.gov/27571944

The value of routine follow-up in patients treated for carcinoma of the vulva

Autor: Harry Hollema, Ate G.J. van der Zee, Maaike H. M. Oonk, Elisabeth Pras, Joanne A. de Hullu, Marian J.E. Mourits, Anke N. M. Wymenga

Publikováno v: Cancer, 98, 12, pp. 2624-9
Cancer, 98(12), 2624-2629. Wiley
Cancer, 98, 2624-9

BACKGROUND Vulvar carcinoma patients traditionally are offered follow-up after their primary treatment because earlier diagnosis of recurrent disease is believed to improve chances for curative treatment. The objective of the current study was to det

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f817249de9be89f3bed36db3c40122
https://pubmed.ncbi.nlm.nih.gov/14669281

Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells

Autor: M A, Stokman, F K L, Spijkervet, A N M, Wymenga, F R, Burlage, W, Timens, J L N, Roodenburg, E G E, de Vries

Publikováno v: Journal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 31(3)

An in-vitro assay has been developed for quantitative assessment of chemotherapy induced oral mucositis. In the present study this method was evaluated for assessment of irradiation mucositis at a cellular level.Ten patients participated in this cons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::54b22d1583b617c544667ea40ef88c35
https://pubmed.ncbi.nlm.nih.gov/11903821